High-dose antipsychotics

Addressing patients' resistance to physical health monitoring

Paula Marie Murphy, Andrew Iles, Suja Sreedharan

Research output: Contribution to journalArticle

Abstract

High-dose antipsychotics are sometimes used in clinical practice when patients fail to respond to treatment at standard doses. Owing to the potential physical complications associated with this, strict adherence to physical health monitoring is essential. Challenges arise for clinicians when patients refuse to cooperate with this monitoring. We discuss different interventions to overcome this problem, many of which are coercive in nature, and consider their professional, ethical and legal implications. We include a flow diagram to assist clinicians in their documentation and decision-making in these circumstances as well as case vignettes showing when monitoring under restraint is and is not justifiable.

Original languageEnglish
Pages (from-to)88-97
Number of pages10
JournalBJ Psych Advances
Volume21
Issue number2
DOIs
Publication statusPublished - 01-01-2015

Fingerprint

Antipsychotic Agents
Health
Documentation
Decision Making
Therapeutics

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health

Cite this

@article{6baef10d18a14e35ab3439f6033db632,
title = "High-dose antipsychotics: Addressing patients' resistance to physical health monitoring",
abstract = "High-dose antipsychotics are sometimes used in clinical practice when patients fail to respond to treatment at standard doses. Owing to the potential physical complications associated with this, strict adherence to physical health monitoring is essential. Challenges arise for clinicians when patients refuse to cooperate with this monitoring. We discuss different interventions to overcome this problem, many of which are coercive in nature, and consider their professional, ethical and legal implications. We include a flow diagram to assist clinicians in their documentation and decision-making in these circumstances as well as case vignettes showing when monitoring under restraint is and is not justifiable.",
author = "Murphy, {Paula Marie} and Andrew Iles and Suja Sreedharan",
year = "2015",
month = "1",
day = "1",
doi = "10.1192/apt.bp.113.011833",
language = "English",
volume = "21",
pages = "88--97",
journal = "BJ Psych Advances",
issn = "2056-4678",
publisher = "Royal College of Psychiatrists",
number = "2",

}

High-dose antipsychotics : Addressing patients' resistance to physical health monitoring. / Murphy, Paula Marie; Iles, Andrew; Sreedharan, Suja.

In: BJ Psych Advances, Vol. 21, No. 2, 01.01.2015, p. 88-97.

Research output: Contribution to journalArticle

TY - JOUR

T1 - High-dose antipsychotics

T2 - Addressing patients' resistance to physical health monitoring

AU - Murphy, Paula Marie

AU - Iles, Andrew

AU - Sreedharan, Suja

PY - 2015/1/1

Y1 - 2015/1/1

N2 - High-dose antipsychotics are sometimes used in clinical practice when patients fail to respond to treatment at standard doses. Owing to the potential physical complications associated with this, strict adherence to physical health monitoring is essential. Challenges arise for clinicians when patients refuse to cooperate with this monitoring. We discuss different interventions to overcome this problem, many of which are coercive in nature, and consider their professional, ethical and legal implications. We include a flow diagram to assist clinicians in their documentation and decision-making in these circumstances as well as case vignettes showing when monitoring under restraint is and is not justifiable.

AB - High-dose antipsychotics are sometimes used in clinical practice when patients fail to respond to treatment at standard doses. Owing to the potential physical complications associated with this, strict adherence to physical health monitoring is essential. Challenges arise for clinicians when patients refuse to cooperate with this monitoring. We discuss different interventions to overcome this problem, many of which are coercive in nature, and consider their professional, ethical and legal implications. We include a flow diagram to assist clinicians in their documentation and decision-making in these circumstances as well as case vignettes showing when monitoring under restraint is and is not justifiable.

UR - http://www.scopus.com/inward/record.url?scp=84924985355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924985355&partnerID=8YFLogxK

U2 - 10.1192/apt.bp.113.011833

DO - 10.1192/apt.bp.113.011833

M3 - Article

VL - 21

SP - 88

EP - 97

JO - BJ Psych Advances

JF - BJ Psych Advances

SN - 2056-4678

IS - 2

ER -